Adherence to the National Quality Forum (NQF) Breast Cancer Measures Within Cancer Clinical Trials: a Review from ACOSOG Z0010

Overview

Journal Ann Surg Oncol

Publisher Springer

Specialty Oncology

Date 2010 Mar 24

PMID 20309640

Citations 5

Authors

Lee G Wilke

Karla V Ballman

Linda M McCall

Armando E Giuliano

Pat W Whitworth

Peter W Blumencranz

Douglas S Reintgen

William E Burak

A Marilyn Leitch

Kelly K Hunt

Affiliations

Soon will be listed here.

Abstract

Background: In 2007, the National Quality Forum (NQF) released four performance measures for the treatment of breast cancer. We proposed to study the degree of adherence with these measures among participating institutions in a multi-institutional trial.

Methods: American College of Surgeons Oncology Group (ACOSOG) Z0010 enrolled breast cancer patients onto a phase II trial studying the prognostic significance of bone marrow and sentinel node micrometastases. The current study used chi(2) analyses to determine the degree of adherence with four NQF measures among three institution types: academic, community, and teaching affiliate.

Results: The study revealed small but important differences in two measures. Ninety-five percent of patients from teaching affiliated institutions received whole-breast radiation compared to 92% at academic and 91% at community hospitals. Among patients who were underinsured or uninsured, a marked decrease in radiation use was noted in comparison to patients with insurance-85 versus 93%, respectively. The study also revealed a difference among institutional types in patients undergoing excisional biopsy for diagnosis. In teaching-affiliated hospitals, 28.6% underwent excisional biopsy as compared to 36.8 and 37.4% in academic and community hospitals, respectively. There was no statistically significant difference between adherence rates with the remaining two measures. Adjuvant chemotherapy was administered to patients with hormone receptor negative tumors > or =1 cm in size in 79-85% of institutions. Tamoxifen was administered to 79-82% of those patients with hormone receptor-positive cancers.

Conclusions: Among breast cancer patients enrolled onto a multi-institutional clinical trial, we found a high degree of adherence with current consensus standards for adjuvant treatment, despite varied practice environments.

Citing Articles

Benchmarking the American Society of Breast Surgeon Member Performance for More Than a Million Quality Measure-Patient Encounters.

Landercasper J, Fayanju O, Bailey L, Berry T, Borgert A, Buras R Ann Surg Oncol. 2017; 25(2):501-511.

PMID: 29168099 PMC: 5758679. DOI: 10.1245/s10434-017-6257-9.

The American Society of Breast Surgeons and Quality Payment Programs: Ranking, Defining, and Benchmarking More Than 1 Million Patient Quality Measure Encounters.

Landercasper J, Bailey L, Buras R, Clifford E, Degnim A, Thanasoulis L Ann Surg Oncol. 2017; 24(10):3093-3106.

PMID: 28766206 PMC: 5594033. DOI: 10.1245/s10434-017-5940-1.

Measures of Appropriateness and Value for Breast Surgeons and Their Patients: The American Society of Breast Surgeons Choosing Wisely (®) Initiative.

Landercasper J, Bailey L, Berry T, Buras R, Degnim A, Fayanju O Ann Surg Oncol. 2016; 23(10):3112-8.

PMID: 27334216 PMC: 4999471. DOI: 10.1245/s10434-016-5327-8.

Evaluating disparities in inpatient surgical cancer care among American Indian/Alaska Native patients.

Simianu V, Morris A, Varghese Jr T, Porter M, Henderson J, Buchwald D Am J Surg. 2016; 212(2):297-304.

PMID: 26846176 PMC: 4939142. DOI: 10.1016/j.amjsurg.2015.10.030.

Challenges in the delivery of quality breast cancer care: initiation of adjuvant hormone therapy at an urban safety net hospital.

Crowley M, McCoy M, Bak S, Caron S, Ko N, Kachnic L J Oncol Pract. 2013; 10(2):e107-12.

PMID: 24345397 PMC: 3948707. DOI: 10.1200/JOP.2013.001164.

References

Wilke L, McCall L, Posther K, Whitworth P, Reintgen D, Leitch A . Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol. 2006; 13(4):491-500. DOI: 10.1245/ASO.2006.05.013. View

Fisher B, Anderson S, Bryant J, Margolese R, Deutsch M, Fisher E . Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002; 347(16):1233-41. DOI: 10.1056/NEJMoa022152. View

Schachter H, Mamaladze V, Lewin G, Graham I, Brouwers M, Sampson M . Many quality measurements, but few quality measures assessing the quality of breast cancer care in women: a systematic review. BMC Cancer. 2006; 6:291. PMC: 1764760. DOI: 10.1186/1471-2407-6-291. View

Cheng S, Wang C, Lin J, Horng C, Lu M, Asch S . Adherence to quality indicators and survival in patients with breast cancer. Med Care. 2009; 47(2):217-25. DOI: 10.1097/MLR.0b013e3181893c4a. View

Brucker S, Schumacher C, Sohn C, Rezai M, Bamberg M, Wallwiener D . Benchmarking the quality of breast cancer care in a nationwide voluntary system: the first five-year results (2003-2007) from Germany as a proof of concept. BMC Cancer. 2008; 8:358. PMC: 2647938. DOI: 10.1186/1471-2407-8-358. View

Buchholz T, Theriault R, Niland J, Hughes M, Ottesen R, Edge S . The use of radiation as a component of breast conservation therapy in National Comprehensive Cancer Network Centers. J Clin Oncol. 2006; 24(3):361-9. DOI: 10.1200/JCO.2005.02.3127. View

Posther K, McCall L, Blumencranz P, Burak Jr W, Beitsch P, Hansen N . Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer. Ann Surg. 2005; 242(4):593-9. PMC: 1402354. DOI: 10.1097/01.sla.0000184210.68646.77. View

Smith B, Smith G, Roberts K, Buchholz T . Baseline utilization of breast radiotherapy before institution of the Medicare practice quality reporting initiative. Int J Radiat Oncol Biol Phys. 2009; 74(5):1506-12. DOI: 10.1016/j.ijrobp.2008.10.012. View

Leitch A, Beitsch P, McCall L, Posther K, Newman L, Herndon 2nd J . Patterns of participation and successful patient recruitment to American College of Surgeons Oncology Group Z0010, a phase II trial for patients with early-stage breast cancer. Am J Surg. 2005; 190(4):539-42. DOI: 10.1016/j.amjsurg.2005.06.024. View

10.

Mandelblatt J, Potosky A . On the road to improving the quality of breast cancer care: a distance still to travel. Med Care. 2008; 46(8):759-61. DOI: 10.1097/MLR.0b013e3181844867. View

11.

. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 365(9472):1687-717. DOI: 10.1016/S0140-6736(05)66544-0. View

12.

Desch C, McNiff K, Schneider E, Schrag D, McClure J, Lepisto E . American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures. J Clin Oncol. 2008; 26(21):3631-7. DOI: 10.1200/JCO.2008.16.5068. View

13.

Hassett M, Hughes M, Niland J, Ottesen R, Edge S, Bookman M . Selecting high priority quality measures for breast cancer quality improvement. Med Care. 2008; 46(8):762-70. PMC: 3538153. DOI: 10.1097/MLR.0b013e318178ead3. View

14.

Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A . Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002; 347(16):1227-32. DOI: 10.1056/NEJMoa020989. View

15.

Malin J, Schneider E, Epstein A, Adams J, Emanuel E, Kahn K . Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States?. J Clin Oncol. 2006; 24(4):626-34. DOI: 10.1200/JCO.2005.03.3365. View